Hot penny stocks... don't get burned
   

News for Hana Biosciences, Inc (HNAB)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Hana Biosciences Inc.  (HNAB) 
|
$ 0.50      -0.11 (-18.03%) Volume: 12.81 k 4:00 PM EDT Oct 6, 2008
Fri, Sep 19, 2008
11:00 AM Video Interview: Steven R. Deitcher, MD, President and CEO, Hana Biosciences - GlobeNewswire
Tue, Sep 09, 2008
7:05 AM Hana Biosciences' rALLy Clinical Trial of Marqibo Meets Response Criteria to Advance to Full Enrollment - GlobeNewswire
Mon, Aug 11, 2008
4:05 PM Hana Biosciences Announces Second Quarter 2008 Results - GlobeNewswire
Thu, Aug 07, 2008
4:05 PM Hana Biosciences to Present At the Canaccord Adams 28th Annual Global Growth Conference - GlobeNewswire
Mon, Jul 28, 2008
7:05 AM Hana Biosciences Announces Conference Call On Second Quarter Financial Results and Business Update - GlobeNewswire
Mon, Jul 14, 2008
7:05 AM Hana Biosciences' Marqibo Receives Orphan Designation From European Commission for the Treatment of Adult Acute Lymphoblastic Leukemia - GlobeNewswire
Thu, Jul 10, 2008
5:32 PM Wall Street Media Presents Exclusive Videos from the Collins Stewart Fourth Annual Growth Conference and the T. Boone Pickens Press Conference - Business Wire
Mon, Jul 07, 2008
4:05 PM Hana Biosciences Announces Schedule Change for Presentation At the Collins Stewart 4th Annual Growth Conference - GlobeNewswire
7:05 AM Hana Biosciences Presents Alocrest and Menadione Data At the European Society for Medical Oncology Conference - GlobeNewswire
Wed, Jul 02, 2008
7:05 AM Hana Biosciences to Present At the Collins Stewart 4th Annual Growth Conference - GlobeNewswire
Mon, Jun 30, 2008
7:05 AM Hana Biosciences Receives U.S. Orphan Drug Designation for Marqibo for the Treatment of Metastatic Uveal Melanoma - GlobeNewswire
Mon, Jun 23, 2008
7:05 AM Hana Biosciences to Present Menadione and Alocrest Data At the European Society for Medical Oncology Conference - GlobeNewswire
Mon, Jun 16, 2008
8:59 AM Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim and Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Acute Leukemia - U.S. Equity News
Fri, Jun 13, 2008
4:27 PM Hana Biosciences Receives Notice From Nasdaq - GlobeNewswire

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for HNAB stock. Download HNAB report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download HNAB report
  
Example preview: Research report for Hana Biosciences, Inc (HNAB) Research report for Hana Biosciences, Inc (HNAB) Research report for Hana Biosciences, Inc (HNAB) Research report for Hana Biosciences, Inc (HNAB)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Hana Biosciences, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.